Quarterly Returns (%)Navidea Biopharmaceuticals Inc
| Years | Q1 | Q2 | Q3 | Q4 | Annual |
|---|---|---|---|---|---|
| 1999 | 0 | -39.8 | 45.2 | -52.2 | 0 |
| 2000 | 204.7 | -45 | -13.9 | -28.8 | -2.3 |
| 2001 | 14.3 | 40 | -41.3 | 20 | 0 |
| 2002 | -9.5 | -24.3 | -58.6 | 8.3 | -69.1 |
| 2003 | -15.4 | 54.6 | 70.6 | 6.9 | 138.5 |
| 2004 | 190.3 | -33.3 | -11.7 | 11.3 | 90.3 |
| 2005 | -22 | -23.9 | -14.3 | -16.7 | -57.6 |
| 2006 | 16 | -10.3 | 26.9 | -27.3 | -4 |
| 2007 | 0 | 8 | 19.2 | -6.5 | 20.8 |
| 2008 | 20.7 | 94.3 | -16.2 | 0 | 96.6 |
| 2009 | -5.3 | 75.9 | 47.4 | -12.9 | 114 |
| 2010 | 34.4 | 9.8 | 10.6 | -28.7 | 63.1 |
| 2011 | 0 | -28.7 | -28.7 | -28.7 | -100 |
| 2012 | 0 | 13.1 | -32.8 | 5.2 | 0 |
| 2013 | -4.2 | 0.4 | -3.3 | -21.9 | -26.9 |
| 2014 | -10.6 | -20 | -10.8 | 43.2 | -8.7 |
| 2015 | -15.9 | 1.3 | 41.6 | -41.7 | -29.6 |
| 2016 | -29.3 | -43.6 | 73.6 | -30.4 | -51.9 |
| 2017 | -9.4 | -12.1 | -17.7 | -16.3 | -43.8 |
| 2018 | 0 | -30.3 | 4.6 | -58.3 | -72.2 |
| 2019 | 40 | 375 | 17.7 | 68.5 | 1130 |
| 2020 | -5 | 4 | 8 | -20.4 | 74.8 |
| 2021 | -6.1 | -9.4 | -4.4 | -42.9 | -53.5 |
| 2022 | -21 | -8.9 | -65.3 | 4 | -74 |